A Single Arm Pilot Study to Refine a Novel Approach to Exercise Promotion Based on Affect-regulation
Completed · Not applicable
Conditions studied: Breast Cancer
In brief
The purpose of this study is to refine the use of an affect-regulated exercise prescription for use with survivors of breast cancer.
Key facts
- Study ID
- NCT04903249
- Run by
- Dartmouth-Hitchcock Medical Center
- People needed
- 37
- Starts
- 2021-08-10
- Expected to finish
- 2022-06-13
- Last updated by the study team
- 2023-07-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Within 5 years of completing curative treatment (surgery, chemotherapy, and radiation) for stage 0-III breast cancer
- <60 mins/week moderate-vigorous physical activity with no major changes for the past 6-months
- Own an Android or iPhone smartphone and willing to use the smartphone to complete app-based surveys during assessment periods
- Willing to wear the ActiGraph monitor during assessment periods
- Access to internet to complete REDCap survey assessments
You may not qualify if…
- Non-English speaking/not able to read English
- Evidence of major contraindications for exercise (informed by the 2020 Physical Activity Readiness-Questionnaire (PAR-Q)+)
- Currently pregnant
- History of severe mental illness or currently taking mood stabilizing medications (antipsychotics, anticonvulsants, or lithium)
- Evidence of moderate-severe depressive symptoms (indicated by a score ≥10 on Patient Health Questionnaire-8)
- Evidence of moderate-severe cognitive impairment (indicated by a score < 3 on a 6-item cognitive screener)
- Evidence of clinically significant substance use as indicated by a score of ≥2 on the CAGE-AID screener
Where it is running
- Dartmouth-Hitchcock Clinic — Lebanon, New Hampshire, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.